Johnson & Johnson OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax
Johnson & Johnson (JNJ) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax of $1.00 million for the 3-month period ending 2024-09-29, per its 10-Q filed 2024-10-23.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax · last filed 2024-10-23
- Johnson & Johnson oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2024-09-29 was $1.00M, a 0.00% change year-over-year.
- Johnson & Johnson oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2024-06-30 was $1.00M, a 0.00% change year-over-year.
- Johnson & Johnson oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2024-03-31 was -$1.00M.
- Johnson & Johnson oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2023-10-01 was $1.00M.
- Johnson & Johnson oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2023 was -$6.00M.
- Johnson & Johnson oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2022 was -$1.00M.
- Johnson & Johnson oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2019 was $0.00.
- Johnson & Johnson oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2018 was $0.00.
| Period end | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 3 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 3 month as first filed | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 6 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 9 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 9 month as first filed | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 12 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2024-09-29 | $1.00M 10-Q · filed 2024-10-23 | $2.00M derived: sum of 2 quarters · filed 2024-10-23 | $1.00M 10-Q · filed 2024-10-23 | ||||
| 2024-06-30 | $1.00M 10-Q · filed 2024-07-25 | $0.00 derived: sum of 2 quarters · filed 2024-07-25 | |||||
| 2024-03-31 | -$1.00M 10-Q · filed 2024-05-01 | ||||||
| 2023-10-01 | $1.00M 10-Q · filed 2024-10-23 | $2.00M derived: sum of 2 quarters · filed 2024-10-23 | $7.00M 10-Q · filed 2024-10-23 | $0.00 derived: sum of 4 quarters · filed 2024-10-23 | |||
| 2023-07-02 | $1.00M 10-Q · filed 2024-07-25 | $6.00M 10-Q · filed 2024-07-25 | -$1.00M derived: sum of 3 quarters · filed 2024-07-25 | -$1.00M derived: sum of 4 quarters · filed 2024-07-25 | |||
| 2023-04-02 | -$5.00M 10-Q · filed 2024-05-01 | -$2.00M derived: sum of 2 quarters · filed 2024-05-01 | -$2.00M derived: sum of 3 quarters · filed 2024-05-01 | -$8.00M derived: sum of 4 quarters · filed 2024-05-01 | |||
| 2023-01-01 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $3.00M derived: sum of 2 quarters · filed 2023-10-27 | -$3.00M derived: sum of 3 quarters · filed 2023-10-27 | -$6.00M 10-K · filed 2023-02-16 | |||
| 2022-10-02 | $0.00 10-Q · filed 2023-10-27 | -$6.00M derived: sum of 2 quarters · filed 2023-10-27 | -$9.00M 10-Q · filed 2023-10-27 | ||||
| 2022-07-03 | -$6.00M 10-Q · filed 2023-07-31 | -$9.00M 10-Q · filed 2023-07-31 | |||||
| 2022-04-03 | -$3.00M 10-Q · filed 2023-04-28 | ||||||
| 2022-01-02 | -$1.00M 10-K · filed 2023-02-16 | ||||||
| 2020-06-28 | -$1.00M 10-Q · filed 2020-07-24 | $0.00 10-Q · filed 2020-07-24 | |||||
| 2020-03-29 | $1.00M 10-Q · filed 2021-04-30 | -$1.00M 10-Q · filed 2020-04-29 | |||||
| 2019-12-29 | $0.00 10-K · filed 2020-02-18 | ||||||
| 2019-06-30 | $0.00 10-Q · filed 2020-07-24 | $0.00 10-Q · filed 2020-07-24 | $0.00 derived: sum of 3 quarters · filed 2020-07-24 | $0.00 derived: sum of 4 quarters · filed 2020-07-24 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-04-29 | $0.00 derived: sum of 2 quarters · filed 2020-04-29 | $0.00 derived: sum of 3 quarters · filed 2020-04-29 | $0.00 derived: sum of 4 quarters · filed 2020-04-29 | |||
| 2018-12-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $0.00 derived: sum of 2 quarters · filed 2020-02-18 | $0.00 derived: sum of 3 quarters · filed 2020-02-18 | $0.00 10-K · filed 2020-02-18 | |||
| 2018-09-30 | $0.00 10-Q · filed 2018-10-31 | $0.00 derived: sum of 2 quarters · filed 2018-10-31 | $0.00 10-Q · filed 2018-10-31 | -$20.00M derived: sum of 4 quarters · filed 2020-02-18 | |||
| 2018-07-01 | $0.00 10-Q · filed 2018-08-02 | $0.00 10-Q · filed 2018-08-02 | -$20.00M derived: sum of 3 quarters · filed 2020-02-18 | -$65.00M derived: sum of 4 quarters · filed 2020-02-18 | |||
| 2018-04-01 | $0.00 10-Q · filed 2018-05-01 | -$20.00M derived: sum of 2 quarters · filed 2020-02-18 | -$65.00M derived: sum of 3 quarters · filed 2020-02-18 | -$48.00M derived: sum of 4 quarters · filed 2020-02-18 | |||
| 2017-12-31 | -$20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -$65.00M derived: sum of 2 quarters · filed 2020-02-18 | -$48.00M derived: sum of 3 quarters · filed 2020-02-18 | -$96.00M 10-K · filed 2020-02-18 | |||
| 2017-10-01 | -$45.00M 10-Q · filed 2018-10-31 | -$28.00M derived: sum of 2 quarters · filed 2018-10-31 | -$76.00M 10-Q · filed 2018-10-31 | -$176.00M derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-07-02 | $17.00M 10-Q · filed 2018-08-02 | -$31.00M 10-Q · filed 2018-08-02 | -$131.00M derived: sum of 3 quarters · filed 2019-02-20 | -$138.00M derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-04-02 | -$48.00M 10-Q · filed 2018-05-01 | $48.00M 10-Q · filed 2017-05-08 | -$148.00M derived: sum of 2 quarters · filed 2019-02-20 | -$155.00M derived: sum of 3 quarters · filed 2019-02-20 | -$78.00M derived: sum of 4 quarters · filed 2019-02-20 | ||
| 2017-01-01 | -$100.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$107.00M derived: sum of 2 quarters · filed 2019-02-20 | -$30.00M derived: sum of 3 quarters · filed 2019-02-20 | -$104.00M 10-K · filed 2019-02-20 | $104.00M 10-K · filed 2017-02-27 | ||
| 2016-10-02 | -$7.00M 10-Q · filed 2017-11-02 | $7.00M 10-Q · filed 2016-11-04 | $70.00M derived: sum of 2 quarters · filed 2017-11-02 | -$4.00M 10-Q · filed 2017-11-02 | $4.00M 10-Q · filed 2016-11-04 | $255.00M derived: sum of 4 quarters · filed 2018-02-21 | |
| 2016-07-03 | $77.00M 10-Q · filed 2017-08-03 | $3.00M 10-Q · filed 2017-08-03 | $262.00M derived: sum of 3 quarters · filed 2018-02-21 | $310.00M derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-04-03 | $74.00M 10-Q · filed 2017-05-08 | $185.00M derived: sum of 2 quarters · filed 2018-02-21 | $233.00M derived: sum of 3 quarters · filed 2018-02-21 | $325.00M derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-01-03 | $111.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $159.00M derived: sum of 2 quarters · filed 2018-02-21 | $251.00M derived: sum of 3 quarters · filed 2018-02-21 | $187.00M 10-K · filed 2018-02-21 | |||
| 2015-09-27 | $48.00M 10-Q · filed 2016-11-04 | $140.00M derived: sum of 2 quarters · filed 2016-11-04 | $76.00M 10-Q · filed 2016-11-04 | $250.00M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-06-28 | $92.00M 10-Q · filed 2016-08-04 | $124.00M 10-Q · filed 2016-08-04 | $202.00M derived: sum of 3 quarters · filed 2017-02-27 | $221.00M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-03-29 | $32.00M 10-Q · filed 2016-05-10 | $110.00M derived: sum of 2 quarters · filed 2017-02-27 | $129.00M derived: sum of 3 quarters · filed 2017-02-27 | $136.00M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2014-12-28 | $78.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $97.00M derived: sum of 2 quarters · filed 2017-02-27 | $104.00M derived: sum of 3 quarters · filed 2017-02-27 | $81.00M 10-K · filed 2017-02-27 | |||
| 2014-09-28 | $19.00M 10-Q · filed 2015-10-30 | $26.00M derived: sum of 2 quarters · filed 2015-10-30 | $3.00M 10-Q · filed 2015-10-30 | $61.00M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-06-29 | $7.00M 10-Q · filed 2015-07-31 | $22.00M 10-Q · filed 2015-07-31 | $42.00M derived: sum of 3 quarters · filed 2016-02-24 | $74.00M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-03-30 | $15.00M 10-Q · filed 2015-05-01 | $35.00M derived: sum of 2 quarters · filed 2016-02-24 | $67.00M derived: sum of 3 quarters · filed 2016-02-24 | $222.00M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-29 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $52.00M derived: sum of 2 quarters · filed 2016-02-24 | $207.00M derived: sum of 3 quarters · filed 2016-02-24 | $48.00M 10-K · filed 2016-02-24 | |||
| 2013-09-29 | $32.00M 10-Q · filed 2014-10-30 | $187.00M derived: sum of 2 quarters · filed 2014-10-30 | $28.00M 10-Q · filed 2014-10-30 | $311.00M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-06-30 | $155.00M 10-Q · filed 2014-08-01 | $60.00M 10-Q · filed 2014-08-01 | $279.00M derived: sum of 3 quarters · filed 2015-02-24 | $423.00M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-03-31 | $95.00M 10-Q · filed 2014-05-02 | $124.00M derived: sum of 2 quarters · filed 2015-02-24 | $268.00M derived: sum of 3 quarters · filed 2015-02-24 | $288.00M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2012-12-30 | $29.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $173.00M derived: sum of 2 quarters · filed 2015-02-24 | $193.00M derived: sum of 3 quarters · filed 2015-02-24 | $136.00M 10-K · filed 2015-02-24 | |||
| 2012-09-30 | $144.00M 10-Q · filed 2013-11-04 | $164.00M derived: sum of 2 quarters · filed 2013-11-04 | $107.00M 10-Q · filed 2013-11-04 | $349.00M derived: sum of 4 quarters · filed 2014-02-21 | |||
| 2012-07-01 | $20.00M 10-Q · filed 2013-08-01 | $37.00M 10-Q · filed 2013-08-01 | $205.00M derived: sum of 3 quarters · filed 2014-02-21 | $264.00M derived: sum of 4 quarters · filed 2014-02-21 | |||
| 2012-04-01 | $57.00M 10-Q · filed 2013-05-03 | $185.00M derived: sum of 2 quarters · filed 2014-02-21 | $244.00M derived: sum of 3 quarters · filed 2014-02-21 | $415.00M derived: sum of 4 quarters · filed 2014-02-21 | |||
| 2012-01-01 | $128.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $187.00M derived: sum of 2 quarters · filed 2014-02-21 | $358.00M derived: sum of 3 quarters · filed 2014-02-21 | $228.00M 10-K · filed 2014-02-21 | $241.00M 10-K · filed 2012-02-23 | ||
| 2011-10-02 | $59.00M 10-Q · filed 2012-11-09 | $230.00M derived: sum of 2 quarters · filed 2012-11-09 | $100.00M 10-Q · filed 2012-11-09 | ||||
| 2011-07-03 | $171.00M 10-Q · filed 2012-08-02 | $159.00M 10-Q · filed 2012-08-02 | |||||
| 2011-04-03 | $12.00M 10-Q · filed 2012-05-07 | ||||||
| 2011-01-02 | $29.00M 10-K · filed 2013-02-22 | -$13.00M 10-K · filed 2011-02-25 | |||||
| 2010-01-03 | -$14.00M 10-K · filed 2012-02-23 | $14.00M 10-K · filed 2011-02-25 | |||||
| 2008-12-28 | -$14.00M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |